CytexOrtho
  • Home
  • Technology
  • News
  • Contact
  • About
    • Mission and Team
    • FAQ
    • Disclosures
  • For Patients
Select Page

Article From ORS on President and CEO Dr. Brad Estes

by CytexOrtho | Jan 3, 2026 | Uncategorized

Brad Estes, PhD Excerpt from the article: “CytexOrtho is based in Durham, North Carolina. We founded CytexOrtho to tackle one of the world’s most pervasive and disabling conditions: osteoarthritis. As this audience well knows, osteoarthritis affects nearly one...

CytexOrtho Newsletter – June 2025

by CytexOrtho | Jul 1, 2025 | Newsletters

”FAQ’S ”Investors follow us Follow...

Cytex Ortho Approval For Clinical Trials

by CytexOrtho | Nov 5, 2024 | In the News

Follow us!

FDA Approves CytexOrtho Hip Human Clinical Trials – New Implants Aim to Regrow Cartilage to Repair Joints

by CytexOrtho | Oct 29, 2024 | In the News

Highly anticipated cartilage repair implant from CytexOrtho receives greenlight to move forward with human clinical trials. Images of CytexOrtho implants DURHAM, N.C., October 29, 2024 /Issuewire.com/ — CytexOrtho, a pioneer in orthopedic joint preservation,...
“Harnessing the Body’s Powerful Ability to Heal”

“Harnessing the Body’s Powerful Ability to Heal”

by CytexOrtho | Jul 29, 2024 | In the News

This Bonezone article by Dan Cook sheds light on three prominent developers in the regenerative medicine field: CytexOrtho, SurGenTec, and Anika Therapeutics. The piece provides an in-depth review of these trailblazing companies’ history and recent advancements....
« Older Entries
Next Entries »

Recent Posts

  • MedTech Jam Session featuring CytexOrtho!
  • Behind the Booth with CytexOrtho
  • CytexOrtho at MedTech World
  • CEO Interview with SmartTRAK
  • 3DHEALS Interview with Dr. Brad Estes

Recent Comments

  1. Steve Scheftic on Breakthrough Device Designation from the FDA
  • Follow
  • Follow
  • Follow
  • Follow

Products are in development. This is potential future technology and not approved by the FDA and not commercially available. The innovations described above are all currently in development. Features and performances of future technologies may vary. Access to future technologies are contingent upon regulatory approval. Approval timelines are subject to the regulatory process of individual countries and regions and not guaranteed.

© 2026 Cytex Therapeutics, Inc now DBA CytexOrtho. All rights reserved